CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq
Insider Sale
+$435,599
-55.09%
Shares
Shares Volume: 18,403 Shares
Average Share Price: $23.67
INSIDER
McWherter Charles
President of R&D (Officer)
reported on Jan 22 2024
traded on Jan 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 15,000 |
| PURCHASES/SALES 1Y | 0 / 8 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $264,004.09 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 31 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $306,957.32 |
| COMPANY PREVIOUS TRADES |